⌘K
Loading ticker…
Lifecore Biomedical, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Lifecore Biomedical, Inc. Common Stock (LFCR) has a 3-month relative strength percentile of 83 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.8%, relative volume 4.32×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 83, Market Stance is mixed at 47, A/D rating C
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LFCR is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional. Top 3 carry $7M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $603K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LFCR Jan avg: -3.12% median: 0.66% win: 50% σ: 12.24% n: 4 2022-11-16 → 2026-05-29 | LFCR Feb avg: 0.57% median: -4.22% win: 25% σ: 19.30% n: 4 2022-11-16 → 2026-05-29 | LFCR Mar avg: -24.75% median: -35.60% win: 25% σ: 30.80% n: 4 2022-11-16 → 2026-05-29 | LFCR Apr avg: 16.45% median: 16.74% win: 75% σ: 16.79% n: 4 2022-11-16 → 2026-05-29 | LFCR May avg: 20.71% median: -0.42% win: 50% σ: 48.17% n: 4 2022-11-16 → 2026-05-29 | LFCR Jun avg: 8.62% median: 18.07% win: 67% σ: 18.02% n: 3 2022-11-16 → 2026-05-29 (current) | LFCR Jul avg: 5.92% median: 8.17% win: 67% σ: 18.69% n: 3 2022-11-16 → 2026-05-29 | LFCR Aug avg: -15.20% median: -23.52% win: 33% σ: 21.03% n: 3 2022-11-16 → 2026-05-29 | LFCR Sep avg: 1.20% median: -3.28% win: 33% σ: 9.91% n: 3 2022-11-16 → 2026-05-29 | LFCR Oct avg: 1.98% median: -2.31% win: 33% σ: 11.69% n: 3 2022-11-16 → 2026-05-29 | LFCR Nov avg: 8.72% median: 6.01% win: 75% σ: 16.16% n: 4 2022-11-16 → 2026-05-29 | LFCR Dec avg: -8.43% median: -6.70% win: 50% σ: 12.71% n: 4 2022-11-16 → 2026-05-29 |